Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Intravitreal injections of pegaptanib every 4 weeks will be efficacious in treating Diabetic Macular Edema (DME), as compared to injections every 6 weeks.
Epistemonikos ID: dfa2044e1293c4a25b8cc38b76ce680d175576f6
First added on: May 10, 2024